" class="no-js "lang="en-US"> Immunologix Laboratories - Medtech Alert
Friday, September 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Immunologix Laboratories | Pharmtech Focus

Immunologix Laboratories

About Immunologix Laboratories

Immunologix Laboratories

Founded in 2012, Immunologix Laboratories is a contract research organization located in Tampa FL that offers GLP and GCP compliant laboratory capabilities focused on ligand binding-based bioanalysis specializing in pharmacokinetic, immunogenicity, and biomarker assays in support of preclinical and clinical studies. Immunologix Translational Sciences Division provides dedicated scientific resources to advise, develop, and implement scientific strategies and practical solutions for innovator development programs.

Related Story

Appointments

 Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO) | Pharmtech Focus

Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO)

August 4 2022

Immunologix Laboratories announced today that Dr. Corinna Fiorotti has been appointed Chief Commercial Officer. An experienced science and business […]